Date of filing of application number => 04/01/2001
Title => COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE  
                                       TREATMENT OF ATHEROSCLEROTIC LESIONS 
 

International Classification => A 61 K 45/06 (71) 
Abstract => This invention is the coadministration of ACAT and MMP inhibitors for the reduction of both the 
macrophage and smooth muscle cell component of atherosclerotic lesions, thus impairing the 
expansion of existing lesions and the development of new lesions and for the prevention of plaque 
rupture and the promotion of lesion regression in a mammal. 
 
Figure: NIL. 
 

